Proteins From Hereditary Eye Diseases: In-silico and Experimental Studies

遗传性眼病的蛋白质:计算机模拟和实验研究

基本信息

  • 批准号:
    7968424
  • 负责人:
  • 金额:
    $ 68.91万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
  • 资助国家:
    美国
  • 起止时间:
  • 项目状态:
    未结题

项目摘要

In order to understand how a pathogenic change in a gene causes disease, it is necessary to recognize a protein structure-function and a role in protein networks. We are looking for a general approach in which computational methods are used to probe the severity of protein structural perturbations caused by pathogenic mutation and to provide a basis for associating these changes with disease phenotype. The implications of such an approach to the kingdom of proteins affected by inherited and degenerative eye disease could create a universal scale to compare effects of mutations at the atomic level, thus, guiding better diagnosis of inherited disease. We successfully applied this approach in molecular modeling of retinoschisin with functional analysis of 27 mutations from 61 X-linked retinoschisis (XLRS) patients and demonstrated that mutational change in RS1 protein structure affects the phenotype of XLRS measured from electroretinogram (manuscript is ready for submission). In 10 pathogenic mutations causing choroideremia missense L550P, truncation and deletion mutants were predicted using computational modeling to be associated with a partial or total loss of the Rab excort protein 1 (REP-1). The presumptive loss of protein was confirmed by Western Blot analysis of protein from mononuclear cells and fibroblasts from CHM patients. Recently, I have applied molecular modeling to explain a functional role of three mutations in the paried box transcription factor gene, PAX2, which may cause papillorenal syndrome. In collaboration with Dr. Brian Brooks I performed molecular modeling of the DNA-PAX2 complex to show a structural effect of these missense mutations. The manuscript describing this work and in which I am a co-author, has received a good review in the PLOS Molecular Genetics and is expected to be accepted. In the experimental part of our work, we have used recombinant protein expression and purification to generate wild type and modified beta-crystallin proteins. Protein folding/misfolding, protein aggregation, subunits exchange, stability and formation of oligomeric homo- and hetero-associates in protein-protein interactions were studied. These characterizations, lead to a better understanding of the different elements of protein structure defining native interactions such as terminal extensions, globular domains and their structural parts. Recently, we demonstrated using site directed mutagenesis, protein expression/purification, limited proteolysis and molecular modeling, that the amino terminal of betaB1 extension contains structural features which position a mobile loop in the vicinity of these processing sites. The loop is derived from residues 48-56 which appear critical for mediating protein interactions with betaA3-crystallin. This work is done in collaboration with Dr. Paul Wingfield (NIAMS) and his laboratory. These results were presented at ARVO meeting 2009 and the manuscript is accepted for publication in Biochemistry. In collaboration with Dr. Sinha laboratory, I used molecular dynamic simulations to show that the 10-residue insertion in betaA3/A1-crystallin creates a loop at the C-terminus that sterically affects protein-protein interactions. This was confirmed by my collaborators who showed aggregation of the mutant betaA3/A1 in the lens. In addition, this study showed for the first time that betaA3/A1 is expressed in the astrocytes, has a novel function in the remodeling of the retina and is also expressed in retinal pigment epithelium cells where it shows age-related macular degeneration (AMD)-like pathology in the aging Nuc1 spontaneous mutant rats.
为了了解基因的致病性变化如何导致疾病,有必要认识蛋白质的结构-功能和蛋白质网络中的作用。我们正在寻找一种通用方法,其中使用计算方法来探测致病突变引起的蛋白质结构扰动的严重性,并为将这些变化与疾病表型相关联提供基础。这种方法对受遗传性和退行性眼病影响的蛋白质王国的影响可以创建一个通用的尺度来比较原子水平上突变的影响,从而指导更好地诊断遗传性疾病。我们成功地将这种方法应用于视网膜劈裂素的分子建模,对 61 名 X 连锁视网膜劈裂症 (XLRS) 患者的 27 个突变进行了功能分析,并证明 RS1 蛋白结构的突变变化影响视网膜电图测量的 XLRS 表型(手稿已准备好提交) 。在导致无脉络膜血症错义 L550P 的 10 种致病性突变中,使用计算模型预测截短和缺失突变体与 Rab 排泄蛋白 1 (REP-1) 的部分或全部丢失相关。对 CHM 患者的单核细胞和成纤维细胞的蛋白质进行蛋白质印迹分析,证实了推定的蛋白质损失。最近,我应用分子模型来解释配对盒转录因子基因 PAX2 中三种突变的功能作用,这可能导致乳头肾综合征。我与 Brian Brooks 博士合作,对 DNA-PAX2 复合物进行了分子建模,以显示这些错义突变的结构效应。我作为合著者描述这项工作的手稿已在《公共科学图书馆分子遗传学》上获得了良好的评论,预计将被接受。 在我们工作的实验部分,我们使用重组蛋白表达和纯化来生成野生型和修饰的 β-晶状体蛋白。研究了蛋白质-蛋白质相互作用中蛋白质折叠/错误折叠、蛋白质聚集、亚基交换、稳定性和寡聚同源和异源缔合体的形成。这些表征有助于更好地理解定义天然相互作用的蛋白质结构的不同元素,例如末端延伸、球状结构域及其结构部分。最近,我们使用定点诱变、蛋白质表达/纯化、有限蛋白水解和分子建模证明,βB1 延伸的氨基末端包含将移动环定位在这些加工位点附近的结构特征。该环源自残基 48-56,这些残基对于介导蛋白质与 betaA3-晶状体蛋白的相互作用至关重要。这项工作是与 Paul Wingfield 博士 (NIAMS) 及其实验室合作完成的。这些结果已在 2009 年 ARVO 会议上发表,手稿已被《生物化学》接受发表。我与 Sinha 博士实验室合作,使用分子动力学模拟表明,βA3/A1-晶状体蛋白中的 10 个残基插入在 C 末端形成了一个环,在空间上影响蛋白质-蛋白质相互作用。 我的合作者证实了这一点,他们展示了突变体 betaA3/A1 在晶状体中的聚集。此外,这项研究首次表明,βA3/A1在星形胶质细胞中表达,在视网膜重塑中具有新功能,并且也在视网膜色素上皮细胞中表达,在视网膜色素上皮细胞中表现出年龄相关性黄斑变性(AMD)衰老的 Nuc1 自发突变大鼠的类似病理学。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Yuri Sergeev其他文献

Yuri Sergeev的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Yuri Sergeev', 18)}}的其他基金

Proteins From Hereditary Eye Diseases: In silico and Experimental Studies
遗传性眼病的蛋白质:计算机模拟和实验研究
  • 批准号:
    10706113
  • 财政年份:
  • 资助金额:
    $ 68.91万
  • 项目类别:
Proteins From Hereditary Eye Diseases: In-silico and Experimental Studies
遗传性眼病的蛋白质:计算机模拟和实验研究
  • 批准号:
    8556850
  • 财政年份:
  • 资助金额:
    $ 68.91万
  • 项目类别:
Proteins From Hereditary Eye Diseases: In-silico and Experimental Studies
遗传性眼病的蛋白质:计算机模拟和实验研究
  • 批准号:
    8938334
  • 财政年份:
  • 资助金额:
    $ 68.91万
  • 项目类别:
Proteins From Hereditary Eye Diseases: In silico and Experimental Studies
遗传性眼病的蛋白质:计算机模拟和实验研究
  • 批准号:
    10020005
  • 财政年份:
  • 资助金额:
    $ 68.91万
  • 项目类别:
Proteins From Hereditary Eye Diseases: In-silico and Experimental Studies
遗传性眼病的蛋白质:计算机模拟和实验研究
  • 批准号:
    8149200
  • 财政年份:
  • 资助金额:
    $ 68.91万
  • 项目类别:
Proteins From Hereditary Eye Diseases: In-silico and Experimental Studies
遗传性眼病的蛋白质:计算机模拟和实验研究
  • 批准号:
    9155585
  • 财政年份:
  • 资助金额:
    $ 68.91万
  • 项目类别:
Proteins From Hereditary Eye Diseases: In-silico and Experimental Studies
遗传性眼病的蛋白质:计算机模拟和实验研究
  • 批准号:
    8737650
  • 财政年份:
  • 资助金额:
    $ 68.91万
  • 项目类别:
Proteins From Hereditary Eye Diseases: In silico and Experimental Studies
遗传性眼病的蛋白质:计算机模拟和实验研究
  • 批准号:
    9362393
  • 财政年份:
  • 资助金额:
    $ 68.91万
  • 项目类别:
Proteins From Hereditary Eye Diseases: In silico and Experimental Studies
遗传性眼病的蛋白质:计算机模拟和实验研究
  • 批准号:
    10930513
  • 财政年份:
  • 资助金额:
    $ 68.91万
  • 项目类别:
Proteins From Hereditary Eye Diseases: In-silico and Experimental Studies
遗传性眼病的蛋白质:计算机模拟和实验研究
  • 批准号:
    8339794
  • 财政年份:
  • 资助金额:
    $ 68.91万
  • 项目类别:

相似国自然基金

HTRA1介导CTRP5调控脂代谢通路在年龄相关性黄斑变性中的致病机制研究
  • 批准号:
    82301231
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
ALKBH5通过SHP-1调控视网膜色素上皮细胞铁死亡在年龄相关性黄斑变性中的作用机制研究
  • 批准号:
    82301213
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
视网膜色素上皮细胞中NAD+水解酶SARM1调控自噬溶酶体途径参与年龄相关性黄斑变性的机制研究
  • 批准号:
    82301214
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
基于疾病进展量化评估的年龄相关性黄斑变性个性化智能诊疗决策系统构建研究
  • 批准号:
    82301208
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
GPC1调控JNK/STAT3信号通路在年龄相关性黄斑变性中的作用及机制研究
  • 批准号:
    82301220
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Deciphering the role of mitochondrial/autophagy dysfunction in regulating inflammatory processes during AMD pathogenesis
破译线粒体/自噬功能障碍在 AMD 发病机制中调节炎症过程中的作用
  • 批准号:
    10664118
  • 财政年份:
    2023
  • 资助金额:
    $ 68.91万
  • 项目类别:
Identifying mechanistic pathways underlying RPE pathogenesis in models of pattern dystrophy
识别模式营养不良模型中 RPE 发病机制的机制途径
  • 批准号:
    10636678
  • 财政年份:
    2023
  • 资助金额:
    $ 68.91万
  • 项目类别:
Regulators of Photoreceptor Aerobic Glycolysis in Retinal Health and Disease
视网膜健康和疾病中光感受器有氧糖酵解的调节因子
  • 批准号:
    10717825
  • 财政年份:
    2023
  • 资助金额:
    $ 68.91万
  • 项目类别:
Cytosolic SINE retrotransposable element cDNA and mitochondrial DNA in aging retina
衰老视网膜中的胞质 SINE 逆转录转座元件 cDNA 和线粒体 DNA
  • 批准号:
    10722062
  • 财政年份:
    2023
  • 资助金额:
    $ 68.91万
  • 项目类别:
Deciphering the role of osteopontin in the aging eye and age-related macular degeneration
破译骨桥蛋白在眼睛老化和年龄相关性黄斑变性中的作用
  • 批准号:
    10679287
  • 财政年份:
    2023
  • 资助金额:
    $ 68.91万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了